表紙
市場調查報告書
商品編碼
960379

一氧化氮吸入療法的全球市場:根據2020-2024年COVID-19的潛在影響,產品類型,應用,最終用戶以及區域考慮因素和預測

Global Inhaled Nitric Oxide Market (by Product Type, Application, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

出版日期: | 出版商: Koncept Analytics | 英文 108 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介
從2020年到2024年,全球一氧化氮吸入療法市場預計將繼續以5.90%的複合年增長率增長,到2024年將達到12.2億美元。市場擴張的驅動力是老年人口的增加,呼吸系統疾病和心臟病,肥胖和哮喘等慢性病的流行,城市化進程的發展,肥胖人口的增加以及新興經濟體的增長。

本報告調查了全球一氧化氮吸入療法市場,並提供了有關COVID-19的影響,全球和區域市場分析,市場動態,競爭條件,公司概況等信息。

目錄

第1章市場概述

  • 簡介
  • 一氧化氮的產生
  • 一氧化氮的生物作用
  • 一氧化氮的合成
  • 一氧化氮的臨床應用
  • 一氧化氮的適應症和劑量
  • 一氧化氮的理想治療目標

第2章COVID-19的影響

  • 經濟影響
  • 自然流量的變化
  • 一氧化氮吸入療法的需求迅速增加
  • 一氧化氮吸入療法和COVID-19

第3章世界市場分析

  • 全球市場概況和預測
  • 按產品類型劃分的市場
    • 純度99.92%
    • 純度99.99%
  • 按應用市場
    • 急性呼吸窘迫綜合徵(ARDS)
    • 新生兒持續性肺動脈高壓(PPHN)
    • 其他
  • 最終用戶的市場
    • 醫院
    • 專科診所,醫療中心
  • 區域市場

第4章區域市場分析

  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲/中東/非洲

第5章市場動態

  • 生長因子
    • 醫療費用增加
    • 老年人口增加
    • 哮喘迅速增加
    • 城市化進程
    • 肥胖人口增加
    • 結核病的檢出率提高
  • 主要趨勢
    • 慢性病患病率上升
    • 擴大煙草消費
    • 持續的研發活動
  • 挑戰
    • 患者風險
    • 治療費用飛漲

第6章競爭情況

  • 世界市場
    • 大公司利潤比較
    • 主要公司市值比較
    • 主要公司的研發比較
    • 主要公司的市場佔有率

第7章公司簡介

  • Linde PLC (Praxair, Inc.)
  • Air Liquide S.A.
  • E. Merck KG
  • Mallinckrodt PLC
  • Beyond Air, Inc.
  • NuMED Plus, Inc.
目錄

The global inhaled nitric oxide market is predicted to reach US$1.22 billion in 2024, witnessing growth at a CAGR of 5.90%, over the period 2020-2024. The factors such as rising healthcare expenditure, increasing geriatric population, surging prevalence of asthma, expanding urbanization, growing obese population and emerging economic growth would drive the growth of the market. However, the market growth would be challenged by associated patient risk and high cost of treatment. A few notable trends include the growing prevalence of chronic diseases, upsurge in cigarette consumption and ongoing research and development activities.

The global inhaled nitric oxide market has been segmented on the basis of product type, application and end-user. In terms of product type, the global inhaled nitric oxide market can be bifurcated into 99.92% purity, 99.995 purity and other purity product. According to application, the inhaled nitric oxide market can be segmented into ARDS (Acute Respiratory Distress Syndrome), PPHN (Persistent Pulmonary Hypertension in the Newborn) and others diseases. Whereas, the inhaled nitric oxide market can be split into hospitals, specialty clinics & healthcare centers and other end-users, on the basis of end-user.

The fastest growing regional market is North America due to rising prevalence of chronic diseases such as respiratory disorders, heart disease, obesity, and asthma, improvements in healthcare infrastructure coupled with growing number of production facilities in the region and increasing research and development activities to improve inhaled nitric oxide applications. Further, the sudden outbreak of COVID-19 would elevate the risk of respiratory distress conditions among the individuals and thereby is expected to accelerate the growth of the global inhaled nitric oxide market in the coming years.

Scope of the report:

  • The report provides a comprehensive analysis of the global inhaled nitric oxide market segmented on the basis of product type, application, end-user and region.
  • The major regional and country markets (North America, Europe, Asia Pacific and LAMEA) have been analyzed.
  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
  • The competitive landscape of the market, along with the company profiles of leading players (Linde PLC (Praxair, Inc.), Air Liquide S.A., E. Merck KG, Mallinckrodt PLC, Beyond Air, Inc. and NuMED, Inc.) are also presented in detail.

Key Target Audience:

  • Inhaled Nitric Oxide Device Manufacturers
  • Inhaled Nitric Oxide Providers and Distributors
  • Pharmaceutical Companies
  • End Users (Hospitals, Specialty Clinics & Healthcare Centers)
  • Government Bodies & Regulating Authorities

Table of Contents

1. Market Overview

  • 1.1 Introduction
  • 1.2 Production of Nitric Oxide
  • 1.3 Biological Roles of Nitric Oxide
  • 1.4 Synthesis of Nitric Oxide
  • 1.5 Clinical Applications of Inhaled Nitric Oxide
  • 1.6 Indications and Dosage for Inhaled Nitric Oxide
  • 1.7 Ideal Treatment Goals for Inhaled Nitric Oxide

2. Impact of COVID-19

  • 2.1 Economic Impact
  • 2.2 Change in Organic Traffic
  • 2.3 Demand Surge for Inhaled Nitric Oxide Therapy
  • 2.4 Nitric Oxide Inhalation & COVID-19

3. Global Market Analysis

  • 3.1 Global Inhaled Nitric Oxide Market by Value
  • 3.2 Global Inhaled Nitric Oxide Market Forecast by Value
  • 3.3 Global Inhaled Nitric Oxide Market by Product Type
    • 3.3.1 Global 99.92% Purity Inhaled Nitric Oxide Market by Value
    • 3.3.2 Global 99.92% Purity Inhaled Nitric Oxide Market Forecast by Value
    • 3.3.3 Global 99.99% Purity Inhaled Nitric Oxide Market by Value
    • 3.3.4 Global 99.99% Purity Inhaled Nitric Oxide Market Forecast by Value
  • 3.4 Global Inhaled Nitric Oxide Market by Application
    • 3.4.1 Global ARDS Inhaled Nitric Oxide Market by Value
    • 3.4.2 Global ARDS Inhaled Nitric Oxide Market Forecast by Value
    • 3.4.3 Global PPHN Inhaled Nitric Oxide Market by Value
    • 3.4.4 Global PPHN Inhaled Nitric Oxide Market Forecast by Value
    • 3.4.5 Global Other Diseases Inhaled Nitric Oxide Market by Value
    • 3.4.6 Global Other Diseases Inhaled Nitric Oxide Market Forecast by Value
  • 3.5 Global Inhaled Nitric Oxide Market by End-User
    • 3.5.1 Global Hospital Inhaled Nitric Oxide Market by Value
    • 3.5.2 Global Hospital Inhaled Nitric Oxide Market Forecast by Value
    • 3.5.3 Global Specialty Clinics & Healthcare Centers Inhaled Nitric Oxide Market by Value
    • 3.5.4 Global Specialty Clinics & Healthcare Centers Inhaled Nitric Oxide Market Forecast by Value
  • 3.6 Global Inhaled Nitric Oxide Market by Region

4. Regional Market Analysis

  • 4.1 North America
    • 4.1.1 North America Inhaled Nitric Oxide Market by Value
    • 4.1.2 North America Inhaled Nitric Oxide Market Forecast by Value
  • 4.2 Europe
    • 4.2.1 Europe Inhaled Nitric Oxide Market by Value
    • 4.2.2 Europe Inhaled Nitric Oxide Market Forecast by Value
  • 4.3 Asia Pacific
    • 4.3.1 Asia Pacific Inhaled Nitric Oxide Market by Value
    • 4.3.2 Asia Pacific Inhaled Nitric Oxide Market Forecast by Value
  • 4.4 LAMEA
    • 4.4.1 LAMEA Inhaled Nitric Oxide Market by Value
    • 4.4.2 LAMEA Inhaled Nitric Oxide Market Forecast by Value

5. Market Dynamics

  • 5.1 Growth Drivers
    • 5.1.1 Rising Healthcare Expenditure
    • 5.1.2 Increasing Geriatric Population
    • 5.1.3 Surging Prevalence of Asthma
    • 5.1.4 Expanding Urbanization
    • 5.1.5 Growing Obese Population
    • 5.1.6 Accelerating Tuberculosis Detection Rate
  • 5.2 Key Trends & Developments
    • 5.2.1 Growing Prevalence of Chronic Diseases
    • 5.2.2 Upsurge in Cigarette Consumption
    • 5.2.3 Ongoing Research and Development Activities
  • 5.3 Challenges
    • 5.3.1 Associated Patient Risk
    • 5.3.2 High Cost of Treatment

6. Competitive Landscape

  • 6.1 Global Market
    • 6.1.1 Revenue Comparison of Key Players
    • 6.1.2 Market Capitalization Comparison of Key Players
    • 6.1.3 R&D Comparison of Key Players
    • 6.1.4 Global Inhaled Nitric Oxide Market Share by Key Players

7. Company Profiles

  • 7.1 Linde PLC (Praxair, Inc.)
    • 7.1.1 Business Overview
    • 7.1.2 Financial Overview
    • 7.1.3 Business Strategies
  • 7.2 Air Liquide S.A.
    • 7.2.1 Business Overview
    • 7.2.2 Financial Overview
    • 7.2.3 Business Strategies
  • 7.3 E. Merck KG
    • 7.3.1 Business Overview
    • 7.3.2 Financial Overview
    • 7.3.3 Business Strategies
  • 7.4 Mallinckrodt PLC
    • 7.4.1 Business Overview
    • 7.4.2 Financial Overview
    • 7.4.3 Business Strategies
  • 7.5 Beyond Air, Inc.
    • 7.5.1 Business Overview
    • 7.5.2 Financial Overview
    • 7.5.3 Business Strategies
  • 7.6 NuMED Plus, Inc.
    • 7.6.1 Business Overview
    • 7.6.2 Business Strategies

List of Figures

  • Types of Nitric Oxide
  • Biological Roles of Nitric Oxide
  • Synthesis of Nitric Oxide
  • Clinical Applications of Inhaled Nitric Oxide
  • Breakdown of Direct and Indirect Costs of COVID-19 (2020)
  • Organic Traffic Growth or Decline due to COVID-19 (2020)
  • Global Increase in COVID Cases (2020)
  • Global Inhaled Nitric Oxide Market by Value (2015-2019)
  • Global Inhaled Nitric Oxide Market Forecast by Value (2020-2024)
  • Global Inhaled Nitric Oxide Market by Product Type (2019)
  • Global 99.92% Purity Inhaled Nitric Oxide Market by Value (2015-2019)
  • Global 99.92% Purity Inhaled Nitric Oxide Market Forecast by Value (2020-2024)
  • Global 99.99% Purity Inhaled Nitric Oxide Market by Value (2015-2019)
  • Global 99.99% Purity Inhaled Nitric Oxide Market Forecast by Value (2020-2024)
  • Global Inhaled Nitric Oxide Market by Application (2019)
  • Global ARDS Inhaled Nitric Oxide Market by Value (2015-2019)
  • Global ARDS Inhaled Nitric Oxide Market Forecast by Value (2020-2024)
  • Global PPHN Inhaled Nitric Oxide Market by Value (2015-2019)
  • Global PPHN Inhaled Nitric Oxide Market Forecast by Value (2020-2024)
  • Global Other Diseases Inhaled Nitric Oxide Market by Value (2015-2019)
  • Global Other Diseases Inhaled Nitric Oxide Market Forecast by Value (2020-2024)
  • Global Inhaled Nitric Oxide Market by End-User (2019)
  • Global Hospital Inhaled Nitric Oxide Market by Value (2015-2019)
  • Global Hospital Inhaled Nitric Oxide Market Forecast by Value (2020-2024)
  • Global Specialty Clinics & Healthcare Centers Inhaled Nitric Oxide Market by Value (2015-2019)
  • Global Specialty Clinics & Healthcare Centers Inhaled Nitric Oxide Market Forecast by Value (2020-2024)
  • Global Inhaled Nitric Oxide Market by Region (2019)
  • North America Inhaled Nitric Oxide Market by Value (2015-2019)
  • North America Inhaled Nitric Oxide Market Forecast by Value (2020-2024)
  • Europe Inhaled Nitric Oxide Market by Value (2015-2019)
  • Europe Inhaled Nitric Oxide Market Forecast by Value (2020-2024)
  • Asia Pacific Inhaled Nitric Oxide Market by Value (2015-2019)
  • Asia Pacific Inhaled Nitric Oxide Market Forecast by Value (2020-2024)
  • LAMEA Inhaled Nitric Oxide Market by Value (2015-2019)
  • LAMEA Inhaled Nitric Oxide Market Forecast by Value (2020-2024)
  • Global Healthcare Expenditure Per Capita (2015-2019)
  • Global Population Above 65 Years (2015-2019)
  • Global Asthmatic Population - Per 100,000 People (2015-2019)
  • Global Urban Population (2014-2019)
  • Global Obese Population (2014-2019)
  • Global Tuberculosis Case Detection Rate (2014-2019)
  • Number of People with Chronic Conditions in the U.S. (2010-2030)
  • Global Cigarette Consumption (2014-2020)
  • Global Inhaled Nitric Oxide Market Share by Key Players (2019)
  • Linde PLC Sales and Net Income (2015-2019)
  • Linde PLC Sales by Region (2019)
  • Air Liquide S.A. Revenue and Net Income (2015-2019)
  • Air Liquide S.A. Revenue by Segment (2019)
  • Air Liquide S.A. Revenue by Region (2019)
  • E. Merck KG Net Sales and Profit (2015-2019)
  • E. Merck KG Net Sales by Segment (2019)
  • E. Merck KG Net Sales by Region (2019)
  • Mallinckrodt PLC Net Sales and Net Income (2015-2019)
  • Mallinckrodt PLC Net Sales by Segment (2019)
  • Mallinckrodt PLC Net Sales by Region (2019)
  • Beyond Air, Inc. Revenue and Profit (2016-2020)

List of Tables

  • Ideal Treatment Goals for Inhaled Nitric Oxide
  • Complications Associated with Inhaled Nitric Oxide Therapeutic Procedures
  • Revenue Comparison of Key Players (2019)
  • Market Capitalization Comparison of Key Players (2020)
  • R&D Comparison of Key Players (2019)